Globotriaosylceramide - Open Access .click

Results 151 to 160 of about 7,739 (261)

Anxiety-like behavior and altered hippocampal activity in a transgenic mouse model of Fabry disease

Neurobiology of Disease
Background: Fabry disease (FD) patients are known to be at high risk of developing neuropsychiatric symptoms such as anxiety, depression and cognitive deficits. Despite this, they are underdiagnosed and inadequately treated.
Kai Kummer +7 more
doaj +1 more source

Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice [PDF]

, 2017
Fabry disease (FD) is an X-linked disorder of glycosphingolipid catabolism resulting in the accumulation of glycolipids including globotriaosylceramide in cells of various tissues resulting in end-organ manifestations.
Cochat, Pierre +9 more
core

The impact of bacteriophages on bacterial pathogenicity [PDF]

, 2019
Mogućnost bakterija da uzrokuju bolest (patogenost) često ovisi o bakteriofagima (fagima). Fagi mogu nositi gene za proteine koje, kad se fag ugradi u bakteriju, može sintetizirati stanična mašinerija bakterije i koji joj mogu biti korisni ili čak ...
Puzek, Barbara
core +2 more sources

Shiga Toxin 2 Affects the Central Nervous System through Receptor Globotriaosylceramide Localized to Neurons